one hundred twenty-four children and young adults with recurrent tumors , predominantly sarcomas , were treated with the combination of ifosfamide , etoposide , and the uroprotector , mesna ( 2-mercaptoethane sulphonate ) , in a phase ii trial .
C1261473
sarcomas
C0020823
ifosfamide